158 related articles for article (PubMed ID: 34023493)
21. Development and application of a recombinant Envelope Domain III protein based indirect human IgM ELISA for Kyasanur forest disease virus.
Rajak A; Kumar JS; Dhankher S; Sandhya VK; Kiran SK; Golime R; Dash PK
Acta Trop; 2022 Nov; 235():106623. PubMed ID: 35940341
[TBL] [Abstract][Full Text] [Related]
22. Phylogeography of Kyasanur Forest Disease virus in India (1957-2017) reveals evolution and spread in the Western Ghats region.
Yadav PD; Patil S; Jadhav SM; Nyayanit DA; Kumar V; Jain S; Sampath J; Mourya DT; Cherian SS
Sci Rep; 2020 Feb; 10(1):1966. PubMed ID: 32029759
[TBL] [Abstract][Full Text] [Related]
23. Development of a quantitative real-time RT-PCR assay that differentiates between Kyasanur Forest disease virus and Alkhurma hemorrhagic fever virus.
N S; Hewson R; Afrough B; Bewley K; Arunkumar G
Ticks Tick Borne Dis; 2020 May; 11(3):101381. PubMed ID: 32009000
[TBL] [Abstract][Full Text] [Related]
24. Clinical and Laboratory Diagnostic Features of Kyasanur Forest Disease: A Study From Wayanad, South India.
Gladson V; Moosan H; Mathew S; P D
Cureus; 2021 Dec; 13(12):e20194. PubMed ID: 35004016
[TBL] [Abstract][Full Text] [Related]
25. Cellular Immune Responses Against γ-Inactivated Antigen in the Recovered Cases of Kyasanur Forest Disease.
Kaushal H; Kartaskar RS; Chiplunkar T; Yadav PD; Awate P; Potdar VA; Khalipe MM; Saraf C; Shete AM; Sahay RR; Das S; Chandrakant SA; Alagarasu K
Viral Immunol; 2024 Mar; 37(2):101-106. PubMed ID: 38315741
[TBL] [Abstract][Full Text] [Related]
26. Kyasanur forest disease: a state-of-the-art review.
Gupta N; Wilson W; Neumayr A; Saravu K
QJM; 2022 Jun; 115(6):351-358. PubMed ID: 33196834
[TBL] [Abstract][Full Text] [Related]
27. Kyasanur forest disease virus breaking the endemic barrier: An investigation into ecological effects on disease emergence and future outlook.
Ajesh K; Nagaraja BK; Sreejith K
Zoonoses Public Health; 2017 Nov; 64(7):e73-e80. PubMed ID: 28220635
[TBL] [Abstract][Full Text] [Related]
28. Clinical & epidemiological significance of Kyasanur forest disease.
Munivenkatappa A; Sahay RR; Yadav PD; Viswanathan R; Mourya DT
Indian J Med Res; 2018 Aug; 148(2):145-150. PubMed ID: 30381537
[TBL] [Abstract][Full Text] [Related]
29. An outbreak of Kyasanur forest disease in the Wayanad and Malappuram districts of Kerala, India.
Sadanandane C; Elango A; Marja N; Sasidharan PV; Raju KHK; Jambulingam P
Ticks Tick Borne Dis; 2017 Jan; 8(1):25-30. PubMed ID: 27692988
[TBL] [Abstract][Full Text] [Related]
30. A preliminary ecological profile of Kyasanur Forest disease virus hosts among the mammalian wildlife of the Western Ghats, India.
Walsh MG; Mor SM; Maity H; Hossain S
Ticks Tick Borne Dis; 2020 Jul; 11(4):101419. PubMed ID: 32241712
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics characterization of envelope glycoprotein from Kyasanur Forest disease virus.
Shil P; Yadav PD; Patil AA; Balasubramanian R; Mourya DT
Indian J Med Res; 2018 Feb; 147(2):195-201. PubMed ID: 29806609
[TBL] [Abstract][Full Text] [Related]
32. Kyasanur Forest Disease, is our surveillance system healthy to prevent a larger outbreak? A mixed-method study, Shivamogga, Karnataka, India: 2019.
Bhat P; S JH; Raju MK; Sooda S; K P; Kumar R
Int J Infect Dis; 2021 Oct; 110 Suppl 1():S50-S61. PubMed ID: 34416404
[TBL] [Abstract][Full Text] [Related]
33. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study.
Broadhurst MJ; Kelly JD; Miller A; Semper A; Bailey D; Groppelli E; Simpson A; Brooks T; Hula S; Nyoni W; Sankoh AB; Kanu S; Jalloh A; Ton Q; Sarchet N; George P; Perkins MD; Wonderly B; Murray M; Pollock NR
Lancet; 2015 Aug; 386(9996):867-74. PubMed ID: 26119838
[TBL] [Abstract][Full Text] [Related]
34. Reviewing the ecological evidence base for management of emerging tropical zoonoses: Kyasanur Forest Disease in India as a case study.
Burthe SJ; Schäfer SM; Asaaga FA; Balakrishnan N; Chanda MM; Darshan N; Hoti SL; Kiran SK; Seshadri T; Srinivas PN; Vanak AT; Purse BV
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009243. PubMed ID: 33793560
[TBL] [Abstract][Full Text] [Related]
35. Forest loss shapes the landscape suitability of Kyasanur Forest disease in the biodiversity hotspots of the Western Ghats, India.
Walsh MG; Mor SM; Maity H; Hossain S
Int J Epidemiol; 2019 Dec; 48(6):1804-1814. PubMed ID: 31740967
[TBL] [Abstract][Full Text] [Related]
36. Study of the clinical manifestations and risk factors in people affected during the first Kyasanur Forest Disease outbreak in Goa, India: A mixed method study.
Kuchelkar SP; Dias A; Gomes E; Dias L
J Vector Borne Dis; 2024 Jan; 61(1):23-28. PubMed ID: 38648403
[TBL] [Abstract][Full Text] [Related]
37. Assessment of NS1 protein as an early diagnostic marker for Kyasanur forest disease virus.
Yadav P; Chaubal G; Jena S; Shil P; Mourya D
J Vector Borne Dis; 2019; 56(3):212-220. PubMed ID: 32655070
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the structural protein gene sequence shows Kyasanur Forest disease virus as a distinct member in the tick-borne encephalitis virus serocomplex.
Venugopal K; Gritsun T; Lashkevich VA; Gould EA
J Gen Virol; 1994 Jan; 75 ( Pt 1)():227-32. PubMed ID: 8113732
[TBL] [Abstract][Full Text] [Related]
39. Sofosbuvir and its tri-phosphate metabolite inhibit the RNA-dependent RNA polymerase activity of non-structural protein 5 from the Kyasanur forest disease virus.
Malik M; Vijayan P; Jagannath DK; Mishra RK; Lakshminarasimhan A
Biochem Biophys Res Commun; 2023 Jan; 641():50-56. PubMed ID: 36521285
[TBL] [Abstract][Full Text] [Related]
40. On the transmission pattern of Kyasanur Forest disease (KFD) in India.
Murhekar MV; Kasabi GS; Mehendale SM; Mourya DT; Yadav PD; Tandale BV
Infect Dis Poverty; 2015 Aug; 4():37. PubMed ID: 26286631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
